BioXcel Therapeutics Inc (BTAI)

BioXcel Therapeutics Inc (BTAI) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 8, 2026: market cap $2.3M; returns 1 year -98.2%.

BioXcel Therapeutics, Inc. (BTAI) is a biopharmaceutical company that utilizes artificial intelligence to develop medicines in neuroscience and immuno-oncology. Their primary focus is on drug re-innovation, leveraging existing approved drugs and clinically validated product candidates with big data and machine learning algorithms to identify new therapeutic indications.

Groups BTAI belongs to

• Biotechnology
• Biopharmaceutical
• Neuroscience
• AI in Healthcare
• Artificial Intelligence
• Healthcare
• Commercial Stage Biotech
• CNS Disorders
• Mental Health Solutions
• Drug Discovery
• Machine Learning

BTAI financial model: income statement, cash flow and balance sheet